Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
2007 · The Journal of Experimental Medicine · 2,356 citations
https://doi.org/10.1084/jem.20062512
D
David J. Friedman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
185
Papers
13.8K
Citations
49
h-index
94
i10-index
David J. Friedman is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Chronic Kidney Disease and Diabetes & Chronic Lymphocytic Leukemia Research. The author has an h-index of 49, co-authored 158 publications.
ORCID: 0000-0002-0301-9298Papers by this author
worksAssociation of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 · Science · 1,994 citations
https://doi.org/10.1126/science.1193032
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
2014 · Kidney International · 351 citations
https://doi.org/10.1038/ki.2014.270
CD39 and control of cellular immune responses
2007 · Purinergic Signalling · 287 citations
https://doi.org/10.1007/s11302-006-9050-y
The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis
2004 · Developmental Biology · 74 citations
https://doi.org/10.1016/j.ydbio.2004.02.010
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
2023 · Nature Communications · 63 citations
https://doi.org/10.1038/s41467-023-43020-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat